Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • Studentlost
    Member
    • Oct 2014
    • 28

    EdgeR confusion with no replicates

    I have four samples(no replicates) in a merged raw counts file from HTSeq. I'm confused on how to create the DGEList and counts via rnbinomial in order to analyze expression levels. The vignette wasn't too clear and I'm not very fluent in R or statistics.

    After reading the raw counts file in and assigning groups I'm not sure what is supposed to be entered for counts.

    Do you guys have a script you can share or can you walk me through the first few lines just to get the object loaded so that I can analyze the data?

    Thank you so much for your help!
  • sdriscoll
    I like code
    • Sep 2009
    • 436

    #2
    Hey there. I usually go about using edgeR a little differently. You can go in with a counts matrix (or data frame) and a single vector defining the conditions of your samples then perform the entire edgeR process like this:

    Code:
    d <- DGEList(counts=counts_table, group=condition_factors)
    d <- calcNormFactors(d)
    d <- estimateCommonDisp(d)
    d <- estimateTagwiseDisp(d)
    d.res <- exactTest(d, pair=c("A", "B")) # where A and B are conditions
    That being said, edgeR does not like unreplicated experiments. I believe it requires that at least one condition is replicated at minimum.
    /* Shawn Driscoll, Gene Expression Laboratory, Pfaff
    Salk Institute for Biological Studies, La Jolla, CA, USA */

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      Nine Things a Sample Prep Scientist Thinks About Before Sequencing
      by SEQadmin2


      I’m not a sequencing expert. I’m a purification scientist who uses NGS to evaluate workflows my group develops. With this perspective, we think about the sample first and the NGS workflow second. The sequencer is an exceptionally honest reporter, but it can only report on what you give it, so whether you get clean, interpretable data from an NGS workflow is largely determined before you begin.


      Here are nine questions we think about, in roughly the order they matter, before...
      Yesterday, 07:11 AM
    • SEQadmin2
      From Collection to Sequencing: Why Sample Preparation and Preservation Define Sequencing Data
      by SEQadmin2


      Data variability is still an issue in sequencing technologies despite the advances in reproducibility and accuracy of these platforms. But the problem does not originate in the sequencing itself, but in the previous steps, before the sample reaches the sequencer.


      The first step is collection, followed by preservation and sample preparation for analysis. Most scientists overlook those steps, but not being careful might just be skewing the experiment’s results.
      ...
      06-02-2026, 10:05 AM
    • SEQadmin2
      Single-Cell Sequencing at an Inflection Point: Early Impacts of New Platforms and Emerging Trends
      by SEQadmin2


      With the launch of new single-cell sequencing platforms in 2026, the field stands at an exciting inflection point. This article surveys the most impactful advances in the field and discusses how they’re reshaping research in cancer, immunology, and beyond.


      Introduction

      Single-cell sequencing technologies have undergone remarkable advances over the past decade, transitioning from low-throughput experimental approaches to highly scalable platforms capable of...
      05-22-2026, 06:42 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 06-17-2026, 06:09 AM
    0 responses
    20 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 06-09-2026, 11:58 AM
    0 responses
    38 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 06-05-2026, 10:09 AM
    0 responses
    44 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 06-04-2026, 08:59 AM
    0 responses
    49 views
    0 reactions
    Last Post SEQadmin2  
    Working...